The current valuation score of Arvinas Inc is 6.73, ranking 298 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.43, which is -9.82% below the recent high of -2.19 and -601.25% above the recent low of -17.05.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.